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Abstract
Recent concern regarding the impact 
of maternal drug abuse on neonatal well 
being was the impetus for this 
retrospective cohort study of newborns 
diagnosed with neonatal abstinence 
syndrome that were discharged from 
Cabell Huntington Hospital during the 
calendar year 2005. Medical records of 
the neonates and their mothers were 
analyzed for a variety of health related 
outcomes and healthcare cost. 
Forty-eight neonates were diagnosed 
with Neonatal Abstinence Syndrome in 
2005, forty of which required NICU 
assistance. The average maternal age at 
delivery was 26; gravity was 3.1 and most 
were single, separated or divorced. The 
majority had poor or inconsistent prenatal 
care. Twenty-one delivered by cesarean 
section most often for fetal distress. Most 
delivered prematurely with an average 
gestation of 35.9 weeks. Half of the 
mothers went into preterm labor with half 
of those having premature ruptured 
membranes. Opiates were the most 
common maternal substance found, while 
neonates most often tested positive for 
methadone. Nearly 90% of the mothers 
smoked. Thirty-four of the mothers were 
found to continue illicit drug abuse while 
pregnant, while another eight were seen 
in a methadone clinic for a history of 
abuse. Most of the neonates required 
weaning with methadone. The majority of 
our study cases were funded by Medicaid, 
mostly by West Virginia with total hospital 
costs exceeding 1.7 million dollars. Direct 
cost attributed to detoxification was in 
excess of $180,000. The number of 
neonates diagnosed with Neonatal 
Abstinence Syndrome has nearly tripled 
from 2003 to 2007.
The problem of maternal drug abuse 
and addiction during pregnancy has 
dramatic effects on both their unborn 
children and our local healthcare system. 
Increased awareness of this growing 
problem is needed so that earlier 
interventions can be implemented. It is 
our opinion that all obstetrical patients at 
risk should be screened early and often 
so that those affected individuals can be 
managed more aggressively to improve 
neonatal outcomes.
Introduction
Neonatal Abstinence Syndrome 
(NAS) consists of a group of 
symptoms caused by neonatal 
withdrawal from maternal use of 
narcotics. The definition has also been 
expanded to include other substances 
(selective serotonin reuptake 
inhibitors, nicotine, amphetamines, 
marijuana, and alcohol). Incidence 
has been difficult to ascertain due 
to poor reporting of maternal drug 
abuse, however, estimates range from 
3 to 50% depending on the patient 
population and area of the country 
studied. At birth, the neonate’s drug 
supply is lost, leading to withdrawal 
within days to weeks depending 
on the half-life of the substance, 
maternal and fetal metabolism, and 
hydration. As many as half of the 
fetuses exposed to narcotics will 
experience withdrawal; while long 
term mortality is extremely low, 
the risk of SIDS (sudden infant 
death syndrome) is increased 
by 3.7% in methadone users and 
2.3% in cocaine users. Withdrawal 
causes central nervous system over 
stimulation as evidenced by high-
pitched cry, restless sleep lasting 
less than 1-3 hours, hyper-reflexia, 
tremors, increased muscular tone, 
myoclonic jerks, and convulsions. 
The gastrointestinal system is also 
affected with excessive suckling, 
poor feeding, regurgitation, emesis 
(often projectile), and loose stools. 
Metabolic, vasomotor and respiratory 
effects include diaphoresis, fevers, 
yawning, sneezing, nasal flaring, 
respiratory rates often greater 
than 60/min. (without retractions) 
and apneic episodes. The rate of 
intrauterine growth restriction, 
preterm rupture of membranes, 
preterm delivery, oligohydramnios, 
low APGAR scores, meconium 
staining and intrauterine fetal 
demise are all increased. Infants 
with NAS, as well as their mothers, 
ultimately require greater care and 
often longer hospitalizations with 
many requiring neonatal intensive 
care unit (NICU) assistance. The 
cost impact of these interventions 
nationwide is largely unknown. It 
has been our observation that the 
diagnosis of NAS has been increasing 
in frequency in our NICU in the past 
five years. It is not the intent of this 
study to establish cause and effect 
but rather to bring attention to the 
scope and the potential impact of the 
problem to our healthcare system. 
Materials and Methods
A retrospective cohort study of 
neonates discharged from Cabell 
Huntington Hospital (CHH) was 
performed during the calendar 
year 2005 with the diagnoses of 
NAS (N=48). CHH, an academic 
tertiary care center in Huntington, 
West Virginia, is the site of over 
2500 live births yearly. The year 
2005 was chosen so that all of 
the records and billing would be 
finalized and so that a comparison 
of the number of affected neonates 
with the two preceding and two 
post characterization years could be 
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made. Before initiating the study, 
The Marshall University Institutional 
Review Board approval was obtained. 
To select the patient population, 
the medical records department 
compiled a list of all infants that 
were discharged from our facility 
during 2005 with an ICD-9 code 
(779.5) for NAS. These neonate’s 
charts were recovered and used to 
identify their mothers whose charts 
were also recovered. Information 
was extracted from both the neonate 
and mother’s charts. Fourteen of the 
maternal charts were not available 
for review since they delivered 
at outlying facilities and only the 
newborn infant was transported 
to our facility. The neonate’s 
chart, however, often contained 
extensive maternal information.
CHH had 2549 live births in 2005. 
Thirty-four (1.3%) of these neonates 
were diagnosed with NAS. Some 
required the services of the NICU 
(N=26), while others were able to 
go to the newborn nursery (N=8). 
Our facility also provides NICU 
services for the surrounding area 
and receives neonatal transfers from 
many outlying hospitals. From these, 
another 14 babies were identified 
with NAS during the time frame 
of our study. The resulting study 
population numbered 48 babies. Of 
the 48, five were twins; therefore, 
our study involved 46 mothers. 
Data was extracted from the 
neonates’ charts (N=48) as well as 
the available maternal charts (N=32, 
since 14 delivered elsewhere). This 
information was recorded onto 
standardized data collection forms by 
the author. Items retrieved included 
drugs used during pregnancy, 
quality of prenatal care, insurance 
status, maternal age, gravity and 
parity, pregnancy and delivery 
complications as well as the mode 
of delivery. Other data collected 
included the percent of expected 
birth weight, gestation age at 
delivery, postpartum complications, 
and total hospital days, which 
were divided into NICU, newborn 
nursery and pediatric days. Maternal 
information was recorded onto the 
corresponding neonate’s data sheet.
To maintain confidentiality, the 
data collection forms were coded 
by numbering 1-48 corresponding 
to the neonates in the study. All 
patient identification information 
was listed separately with the 
corresponding codes and known only 
to the author. The data collection 
forms were maintained and stored 
confidentially in the OB/GYN 
office at Marshall University. The 
code sheet was stored separately 
by the author. Once the study 
was completed, the identification 
code sheet was shredded.
The drugs involved were 
determined by examination of both 
the neonate’s and their mother’s 
charts. Maternal drugs were 
identified by a positive maternal 
drug screen, positive neonatal 
urine, meconium testing, or 
admission by the mother of using 
a substance during her pregnancy. 
Neonatal drugs were determined 
only by positive testing of the 
infant’s urine or meconium.
The total cost of hospitalization 
for the 48 neonates was compiled by 
the billing department of CHH. The 
average cost of stay was calculated 
by dividing the total by 48. A 
comparison between the average cost 
of stay of a healthy newborn with 
the average cost of stay of a newborn 
with NAS and no other health 
issues was made. The difference 
in the cost of caring for these two 
neonates was the direct cost of 
detoxification for the treatment of 
NAS. This number was multiplied 
by 48 for the total cost of care 
directly attributed to detoxification.
Raw numbers of infants carrying 
the diagnoses of NAS were obtained 
(by ICD-9 code search by our medical 
records department) for the two 
years prior and two years after 2005. 
Neither maternal nor neonate charts 
were examined for this purpose.
Results
During the calendar year 
2005, forty-eight neonates were 
discharged with the diagnosis of 
neonatal abstinence syndrome. 
Of these, 33 were delivered at our 
facility, 14 were transported to our 
facility after being delivered at 
outlying hospitals and 1 delivered 
at home. Of the 33 delivering at 
Cabell Huntington Hospital, 7 
arrived as maternal transports 
for pregnancy complications. 
Forty three of the cohort were 
singletons (89.6%) and 5 were 
twins (10.4%) [One corresponding 
twin was not transported from the 
outlying hospital where delivered]. 
Interestingly, 37 were male (77.1%) 
while 11 were female (22.9%).
Maternal age at delivery ranged 
from 18 to 38 years old with an 
average age of 26.1 years. Most were 
PRENATAL CARE FIRST APPOINTMENT CONSISTENCY WOMEN
GOOD CARE Starting in 1st trimester No missed appointments 13
LATE CARE Starting after 1st trimester +/- missed appointments 4
VERY LATE CARE Starting after 2nd trimester +/- missed appointments 9
INCONSISTENT CARE Starting in 1st trimester Missed >2 appointments 17
NO CARE --------------------------------- --------------------------------- 2
UNKNOWN CARE --------------------------------- --------------------------------- 1
Table 1. Prenatal Care Patterns
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Figure 1.
Gestation at delivery.
in their 20’s (N=36, 78.3%), 9 were 
in their 30’s (19.6%) and one was 
less than 20 (2.1%). Gravity ranged 
from 1 to 12 with an average of 
3.1 pregnancies per mother. Parity 
ranged from zero to 6 yielding 
71 children delivered to this 
population previously, of which 15 
were preterm (21.1%) and 5 were 
documented fetal demises at greater 
than 20 weeks gestation (7.0%). 
Twenty-nine previous spontaneous 
abortions were also reported. 
Most mothers were single (N=20, 
43.4%), 15 were married (32.6%), 
10 were divorced or separated 
(21.7%) and one was widowed. 
Twenty-one cesarean sections 
(45.7%) were performed and 
comprised of 12 primary low 
transverse, 1 primary classical 
and 8 repeat low transverse. 
Reasons for caesarian section 
included: fetal distress (8), severe 
preeclampsia (1), abruption (2), 
malpresentation (3), Hepatitis C 
(3), twins (3) and unknown (1). The 
remaining 25 mothers delivered 
vaginally (54.3%) with one requiring 
vacuum assistance and another 
necessitating forceps. One delivery 
was a vaginal birth after cesarean. 
The average gestational age 
at delivery was 35 6/7 weeks 
with a range of 26 0/7 to 42 0/7 
weeks (Figure 1). Prenatal care 
was frequently either late and/
or inconsistent or no care at all 
(Table 1). Eleven mothers were 
seen by maternal fetal medicine 
and every obstetric practice in 
our area was involved in the 
care of some of these women.
Opiates were the most common 
maternal substance found, while 
neonates most often tested positive 
for methadone (Figure 2). Drug 
test results could not be found for 
11 of the mothers and 14 of the 
neonates. It was unclear if these 
tests were ordered. Negative testing 
was identified in 2 mothers and 9 
neonates. Seven mothers (15.2%) 
readily admitted to using alcohol 
during the reference pregnancy, 
with one admitting to drinking 
“almost every day.” Forty one 
mothers smoked (89.1%) while 
three denied smoking (6.5%) and 
2 were undeterminable (4.3%).
Of the 19 mothers positive for 
methadone, 6 were buying the drug 
on the street, 2 had prescriptions from 
their physicians, while the remaining 
11 went to methadone clinics. Eleven 
of the 13 were taking methadone due 
to a history of narcotic abuse and for 
the prevention of withdrawal while 
pregnant. The remaining two had 
chronic low back pain, both from 
motor vehicle accidents. Methadone 
doses ranged from 20 mg to 140mg 
daily (average dose 98.5mg daily).
Prescription medications other 
than methadone were used by 6 
mothers. One took oxycodone/
acetaminophen for low back pain 
(spinal stenosis), while another 
took oxycodone/acetaminophen 
for osteoarthritis. One mother 
was prescribed oxycodone CR 
for restless leg syndrome and 
another took acetaminophen with 
codeine for a childhood sports 
injury to her thoracic spine. One 
woman took both oxycodone and 
alprazolam for chronic pain caused 
by an automobile accident and its 
provocation of anxiety attacks. The 
last took clonazepam for her anxiety. 
While none of the mothers 
spent excess time in the hospital 
postpartum, six spent time on the 
antepartum unit. The longest stay 
was for 17 days for “fetal well 
being” following an ethics consult. 
One was directly admitted from 
the Emergency Department after 
presenting in withdrawal. She stayed 
9 days before having an emergent 
cesarean section for fetal distress. 
Other antepartum admissions 
included one for oligohydramnios, 
one for preeclampsia, and 
two for pre-term labor.
Within this cohort (N=46) there 
were numerous complications with 
both the pregnancies as well as the 
deliveries. Half of these women 
went into preterm labor (N=23). 
Twelve had premature rupture 
of membranes (26.1%) with 9 
occurring preterm (19.6%). Many 
placental complications were seen 
including: abruption (N=6, 13.0%), 
previa (N=2), velamentous cord 
insertion (N=1), and accreta (N=2) 
with one requiring a hysterectomy. 
Documentation revealed 5 cases 
of chorioamnionitis, 14 cases of 
meconium stained amniotic fluid 
and 4 cases of oligohydramnios. 
Non-reassuring fetal heart tracings 
were noted in 15 of the pregnancies 
(32.6%). Five precipitous deliveries 
occurred—with one delivery at 
home. While most of the fetuses 
were in the vertex presentation 
at delivery (N=42, 91.3%), 5 were 
malpositioned. Of these, three were 
breech (two frank and one footling), 
one was transverse, and one was 
direct occiput posterior. Two had 
undocumented presentations, 
but delivered vaginally.
Neonatal complications were 
numerous. By design, all of the 
neonates had neonatal abstinence 
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syndrome (N=48), most of which 
were directly related to current or 
past use of illicit substances (N=42, 
91.3%) (Figure 3). Because of their 
dependence, twenty six (54.2%) of 
the neonates required weaning with 
methadone totaling 215 days with 
23 going home on this medication 
for continued weaning as an 
outpatient. Of these: 11 necessitated 
outpatient apnea monitoring as 
well. Thirteen required respiratory 
assistance totaling 7 days of high 
frequency ventilation, 19 days regular 
ventilation, 83 days of continuous 
positive airway pressure (CPAP), and 
numerous days of oxygen assistance. 
Two neonates were lethargic at birth 
and one required cardiopulmonary 
resuscitation and administration of 
naloxone. One was noted to have 
elevated liver enzymes caused by in 
utero anoxic hepatic injury. Fifteen 
other neonates were found to have 
hyperbilirubinemia requiring 63 
total days of light therapy. One 
child had culture proven septicemia 
with MRSA, while 21 others had 
suspected sepsis, but with negative 
cultures. These children were given 
IV antibiotics for a total of 127 days. 
Thirteen were diagnosed with anemia 
of which 5 needed transfusions and 
4 received epoetin alfa. Two also 
received fresh frozen plasma. 
Other serious complications 
included intraventicular hemorrhages 
(2), bilateral pneumothorax (1), 
pulmonary hemorrhage (1), GI bleed 
(1), intrauterine growth restriction 
(9) and large for gestational age (3) 
(Figure 4). In addition to serious 
complications there were an unusual 
number of anomalies identified 
which included distal rectal atresia 
(1), peripheral pulmonary artery 
branch stenosis (1), microcephaly 
(1), syndactyly (2), umbilical/
inguinal hernias (1) and three 
failed hearing examinations. 
Of the 48 neonates, 40 required 
NICU assistance (83.3%) for a total of 
650 days (range 1-55 days, average 
stay 16.25 days). An additional 36 
days were spent in the well child 
nursery and 13 days on the pediatric 
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Figure 2.
Substances involved during the reference pregnancy.
Figure 3.
Substance Source by Neonate [N=48]: 1) 
History of illicit drug abuse now going 
to Methadone Clinic, with no evidence 
of continued abuse [N=8]. 2) History of 
illicit drug abuse now going to Methadone 
Clinic and continuing illicit abuse [N=4]. 
3) Continued illicit abuse [N=27]. 4) 
Prescription medication from a physician 
and continuing illicit abuse [N=3]. 5) 
Prescription medication from a physician, 
with no evidence of illicit abuse [N=3]. 
6) Methadone from a physician [N=2]. 7) 
Given long term narcotics in the NICU 
for pain relief [N=1].
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service. Two babies were transported 
back to outlying hospitals prior to 
discharge. Most of the neonates were 
discharged home with their mothers 
(N=31, 64.6%), while 5 went with 
relatives (usually a grandparent), 
11 went to foster care (22.9%) and 
one was unknown. Of interest, one 
child reported to the emergency 
department in cardiopulmonary 
arrest just 9 days after being 
discharged home with his mother 
and grandmother. He had severe 
anoxic ischemic encephalopathy 
and died 3 days later.
The majority of our patients had 
health insurance and were covered 
by Medicaid (N=38, 79.2%) most 
of which were from West Virginia 
(N=22) but neighboring states Ohio 
(N=11) and Kentucky (N=5) were 
also well represented. Three had 
no coverage at delivery, but later 
received Medicaid and only a few 
had private insurance (N=7, 14.6%). 
Total cost for the care of these 48 
neonates while hospitalized exceeded 
$1,761,582 at an average of $36,700 
per child. This figure represents 
hospitalization costs only for the 
neonates, not their mothers, and 
does not include physician costs. 
The hospitalization cost for a healthy 
newborn going to the newborn 
nursery was determined by averaging 
the cost of all such neonates in 2005. 
This group had an average stay of 
2.3 days at a cost of $1,964.16 each. 
The average cost for neonates with 
NAS who were otherwise healthy 
was then calculated. This group 
spent an average of 5 days at a cost 
of $5,898.71 each. The difference 
between these two groups ($3,934.55) 
is the excess charge attributed 
to detoxification of one neonate. 
Multiplying this amount by 48, (the 
number of neonates in our study) 
produces $188,858.40 spent in 2005 
for detoxification alone. It was not 
possible to relate the remaining NICU 
costs directly to maternal drug abuse 
but an obvious inference can be made 
since the rate of NICU admissions 
from our cohort is much greater 
than that of the general population.
Lastly, review of the raw numbers 
of neonates diagnosed with NAS in 
the two years prior to 2005 as well as 
the two years after 2005 demonstrates 
a clear upward trend (Figure 5).
Discussion
All cases of Neonatal Abstinence 
Syndrome caused by maternal drug 
abuse are preventable. Throughout 
history, men and women have used 
a wide array of substances to cause 
various effects within their bodies 
and this experimentation is very 
unlikely to change. Unfortunately, 
within our pregnant population this 
trend is increasing bringing with it 
an increase in neonatal morbidity 
and mortality as well as increasing 
strain on our healthcare system. 
Most of the women in our 
cohort study received either late 
or inconsistent prenatal care with 
some receiving no care at all ( Table 
#1). Forty-one neonates were either 
covered by Medicaid at the time 
of delivery or shortly thereafter. 
This group represents 85.4% of 
our study population indicating 
the involvement of socioeconomic 
factors. It is essential, however, that 
N=3,6%
N=16,33%
N=20,42%
N=8,17%
N=1,2%
<5%(SevereIUGR) 5to<10%(IUGR) 10to<50%(LowNormal)
50to90%(HighNormal) >90%(LargeforGestation)
Figure 4.
Birth weight expressed as the percentage expected for gestational age at delivery.
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the physician practicing obstetrics be 
mindful that the problems leading to 
NAS cross all socioeconomic levels. 
The population characterized 
in this study ranged from 18 to 38 
years of age, which encompasses 
the full age range of fertile women. 
It is apparent that no age group can 
be excluded from scrutiny when 
thinking about the possibility of 
substance abuse in pregnancy. 
The greater majority of those 
studied were either single, 
separated or divorced (N=30) 
indicating a potential lack of 
stability and commitment in their 
lives. Practitioners need to note 
however, that fifteen of the women 
were married; once again making it 
difficult to determine whom to screen 
for potential problems with abuse.
Most drug abusers will not be 
identified unless all obstetric patients 
are screened. Even then, denial is 
a major obstacle, especially in the 
pregnant population. Women may 
not admit to drug abuse for fear of 
loss of custody, legal ramifications, 
or guilt. Careful history taking 
is important. The interviewer 
must be respectful, attentive and 
understanding while asking neutral 
open-ended questions. It is useful to 
begin asking about legal substances 
such as cigarette smoking, alcohol 
consumption and prescription 
medication. Marijuana, while illegal, 
carries less social stigma and women 
may respond truthfully if asked 
about its use. Questions about clearly 
illegal substances such as cocaine, 
heroin, and methamphetamines 
will complete the review. 
For each substance, ask the 
dosage, frequency and the last 
time used. The route of dosage is 
important since IV drug abuse is 
closely related to infectious diseases, 
many of which have serious 
consequences for both the mother 
and fetus. A history of sharing 
needles is particularly worrisome. 
Risk factors include late or 
inconsistent prenatal care, past 
history of spontaneous abortions, 
premature birth, growth retardation, 
abruptions, precipitous delivery, 
or stillbirths. Trouble with law 
enforcement, child protective services 
involvement, and having children 
removed from the home should 
raise questions. Family history of 
substance abuse as well as substance 
abusing spouses, especially in 
patients with risk factors of their own, 
are especially worrisome since often 
a family member or the spouse is the 
initiating factor. Mothers of children 
with neurological or developmental 
problems should also raise concern. 
Certain infectious diseases 
and illnesses are often associated 
with substance abuse. HIV, 
hepatitis, endocarditis and sexually 
transmitted diseases should raise 
questions about IV drug abuse 
or trading sex for drugs. Physical 
findings such as needle tract marks, 
atrophy of the nasal septum, 
tachycardia, and abnormalities 
of pupil size, diaphoresis, or 
behavior that is deemed as 
abnormal should raise concern. 
Practicing physicians treating 
female patients must be cognizant 
of the possibility of drug abuse in 
pregnancy recognizing that the 
problem crosses all socioeconomic, 
age and race boundaries. An increase 
in awareness leads to opportunities 
for early interventions and aggressive 
management that in turn leads to 
better outcomes. Proper screening 
techniques, good history taking 
skills and thorough physical 
examinations are necessary to alert 
the clinician to potential substance 
abuse. Risk factors must be evaluated 
carefully and tactfully. Once abuse 
is identified, it becomes imperative 
to develop a treatment plan with 
the patient. Special consideration 
of the desire to quit, the substance 
involved, the dosage, and gestational 
age must be considered. With ample 
time, psychiatric counseling, and 
social services support, almost any 
motivated patient can be detoxified. 
If any of these requirements are 
absent, the mother can be placed 
on a methadone maintenance 
program with reasonable success, 
understanding that the newborn 
will require detoxification.
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Neonates diagnosed with Neonatal Abstinence Syndrome by year. Dashed line shows 
trend increasing (binomial regression).
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